Lilly, Walmart launch discount retail option for weight-loss drug Zepbound
Go back to Lilly, Walmart launch discount retail option for weight-loss drug Zepbound| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1242.41 -12.99 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1255.40 | 52 Week High | $88.16 | |||
| Open | $1262.14 | 52 Week Low | $67.88 | |||
| Day High | $1262.14 | P/E | 287.59 | |||
| Day Low | $1230.95 | EPS | $4.32 | |||
| Volume | 778,848 | |||||
| Wal-Mart Stores (NASDAQ: WMT) | Delayed: 104.84 +1.14 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.70 | 52 Week High | $75.19 | |||
| Open | $104.14 | 52 Week Low | $56.36 | |||
| Day High | $105.54 | P/E | 21.62 | |||
| Day Low | $104.00 | EPS | $4.85 | |||
| Volume | 16,372,913 | |||||
